Gain Therapeutics, Inc. (GANX)

NASDAQ: GANX · IEX Real-Time Price · USD

2.970

+0.040 (1.37%)

At close: May 1, 2024, 4:00 PM

3.080

+0.110 (3.70%)

Pre-market: May 2, 2024, 7:36 AM EDT

Gain Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	48	42	37	65	-	-
Market Cap Growth	-	13.33%	-42.34%	-	-	-
Enterprise Value	32	26	18	29	-6	-0
PE Ratio	-1.89	-1.89	-2.11	-4.64	-	-
PS Ratio	873.01	763.91	265.47	390.97	-	-
PB Ratio	3.83	3.35	1.97	1.85	-	-
P/FCF Ratio	-2.23	-2.23	-2.51	-5.18	-	-
P/OCF Ratio	-2.23	-2.23	-2.53	-5.22	-	-
EV/Sales Ratio	587.26	478.16	130.83	177.19	-216.16	-2.34
EV/EBITDA Ratio	-1.19	-1.19	-1.05	-2.11	1.75	0.04
EV/EBIT Ratio	-1.19	-1.19	-1.05	-2.11	1.75	0.04
EV/FCF Ratio	-1.40	-1.40	-1.24	-2.35	1.91	0.05
Debt / Equity Ratio	0.08	0.08	0.07	0.05	0.20	-0.46
Debt / EBITDA Ratio	-0.05	-0.05	-0.07	-0.12	-0.35	-0.10
Debt / FCF Ratio	-0.05	-0.05	-0.09	-0.13	-0.39	-0.11
Quick Ratio	3.39	3.39	4.88	14.45	3.55	0.35
Current Ratio	3.59	3.59	5.11	14.78	4.25	0.49
Asset Turnover	0.00	0.00	0.01	0.00	0.01	-
Interest Coverage	-	-	-	-	-	-105.44
Return on Equity (ROE)	-193.00%	-193.00%	-70.10%	-35.10%	-124.40%	-
Return on Assets (ROA)	-123.20%	-123.20%	-57.70%	-31.80%	-69.70%	-
Return on Capital (ROIC)	-163.56%	-163.56%	-88.21%	-37.96%	-46.62%	863.22%
Earnings Yield	-46.22%	-52.83%	-47.29%	-21.53%	-	-
FCF Yield	-39.20%	-44.79%	-39.82%	-19.32%	-	-
Buyback Yield / Dilution	-9.49%	-9.49%	-16.90%	-279.11%	-19.17%	-
Total Shareholder Return	-9.49%	-9.49%	-16.90%	-279.11%	-19.17%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).